Which of the following is a treatment option for chronic glomerulonephritis?

Chronic glomerulonephritis is a progressive kidney disease characterized by inflammation and damage to the glomeruli, which can lead to renal failure. Treatment options are aimed primarily at managing the condition and its complications, as well as slowing disease progression.

ACE inhibitors are particularly important in the management of chronic glomerulonephritis due to their ability to reduce proteinuria and lower blood pressure. They help in protecting the remaining kidney function by reducing the pressure in the glomeruli. This is crucial because elevated blood pressure can exacerbate the condition and lead to further renal damage.

In contrast, while insulin therapy is essential for managing diabetes, it does not address glomerulonephritis directly. Antidepressants may be used for associated mental health conditions but have no role in treating the underlying kidney disease. Opioids are primarily pain management medications, which are also not relevant to the treatment of chronic glomerulonephritis itself.

Thus, ACE inhibitors stand out as an effective and direct treatment approach for managing chronic glomerulonephritis.